Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Novel allogeneic BCMA CAR-expressing iNKT cells with PD1 deletion demonstrate superior tumor control in a multiple myeloma preclinical model

Yuhua Wan, Dexian Quan, Shulin Yang, Mo Deng, Feng Xu, Biao Zhou, Yuzhu Cui, Linyan Deng, Jian Hua, Jingyu Li, Hua Zhang

Blood (2025) 146 (Supplement 1): 5847.

https://doi.org/10.1182/blood-2025-5847

Published: 2025

Journal Articles

Multicenter prospective Phase II study of decitabine priming combined with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 5233.

https://doi.org/10.1182/blood-2025-5233

Published: 2025

Journal Articles

Low-dose chemotherapy for induction in pediatric AML: Retrospective outcome analysis across expanded cohorts

Blood (2025) 146 (Supplement 1): 1661.

https://doi.org/10.1182/blood-2025-1661

Published: 2025

Journal Articles

Alternative splicing of its 5′-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies

Blood (2023) 142 (20): 1724–1739.

https://doi.org/10.1182/blood.2023020400

Published: 2023

Includes: Supplemental data

Journal Articles

DNMT3A wt NPM1-Mutation Defines a Subgroup of MDS with Special Favorable Outcomes Towards Decitabine Therapy

Lingyun Wu, MD PhD, Xiao Li, MD, Feng Xu, He Qi, Zheng Zhang, Dong Wu, Luxi Song, MD, Liyu Zhou, Chao Xiao, Jiying Su, Juan Guo, Chunkang Chang

Blood (2019) 134 (Supplement_1): 1724.

https://doi.org/10.1182/blood-2019-124008

Published: 2019

Journal Articles

Incidence, Clinical Characteristics and Outcome of Cardiac Toxicity in Elderly Patients with Diffuse Large B-Cell Lymphoma

Wei Ping Liu, Yan Feng Xu, Yan Xie, Xiaopei Wang, MD, Yuqin Song, MD PhD, Jun Zhu, MD PhD

Blood (2018) 132 (Supplement 1): 5416.

https://doi.org/10.1182/blood-2018-99-117955

Published: 2018

Journal Articles

Dysregulation of ANKRD11 Influenced Hematopoisis By Histone Acetylation-Mediated Gene Expression in Myelodysplastic Syndrome

Youshan Zhao, MD, Feng Xu, Juan Guo, MD, Sida Zhao, MD, Chunkang Chang, MD PhD, Xiao Li, MD PhD

Blood (2016) 128 (22): 4292.

https://doi.org/10.1182/blood.V128.22.4292.4292

Published: 2016

Journal Articles

Ribosomal Protein L23 Negatively Regulates Cell Apoptosis Via Its Suppression of Miz1 and Activation c-Myc in Higher-Risk Myelodysplastic Syndromes

Yuekun Qi, Lingyun Wu, Chunkang Chang, MD PhD, Feng Xu, Qi He, Xiao Li, MD PhD

Blood (2016) 128 (22): 5508.

https://doi.org/10.1182/blood.V128.22.5508.5508

Published: 2016

Journal Articles

A Primary Study of the Gene Mutations in Predicting Treatment Response to Decitabine in Patients with MDS

Chunkang Chang, MDPhD, Youshan Zhao, MD, Feng Xu, Xiao Li, MD PhD

Blood (2015) 126 (23): 1689.

https://doi.org/10.1182/blood.V126.23.1689.1689

Published: 2015

Journal Articles

DHX9 Mutations Are Identified As a Novel Recurrent Event in Patients with Myelodysplastic Syndromes and Closely Related to Bone Marrow Failure

Wenhui Shi, Feng Xu, Chunkang Chang, MDPhD, Xiao Li, MD PhD

Blood (2015) 126 (23): 1651.

https://doi.org/10.1182/blood.V126.23.1651.1651

Published: 2015

Journal Articles

EZH2-Mediated Activation of Serine Biosynthetic Pathway Is Critical for Resistance of Clonal Cells to Stress-Related Apoptosis in Low-Grade Myelodysplastic Syndrome

Feng Xu, Chunkang Chang, MDPhD, Wenhui Shi, Xiao Li, MD PhD

Blood (2015) 126 (23): 1660.

https://doi.org/10.1182/blood.V126.23.1660.1660

Published: 2015

Journal Articles

Downregulation of Dicer1 Promotes Cellular Senescence and Decreases the Differentiation and Stem Cell-Supporting Capacities of MSCs in Patients with Myelodysplastic Syndrome

Youshan Zhao, Dong Wu, Chengming Fei, Juan Guo, Shucheng Gu, Feng Xu, Zheng Zhang, Chunkang Chang, Xiao Li, MD PhD

Blood (2014) 124 (21): 4365.

https://doi.org/10.1182/blood.V124.21.4365.4365

Published: 2014

Journal Articles

Cytogenetic Response Based On Revised IPSS Cytogenetic Risk Stratification and Minimal Residual Disease Monitoringby FISH In MDS Patients Treated By Low-Dose Decitabine

Xiao Li, MD, PhD, Chunkang Chang, Qi He, Feng Xu, Qingxia Zhang, Lingyun Wu, Jiying Su, Xi Zhang, Liyu Zhou, Dong Wu, Zheng Zhang

Blood (2013) 122 (21): 1575.

https://doi.org/10.1182/blood.V122.21.1575.1575

Published: 2013

Journal Articles

Efficacy and Toxicity Of Decitabine Versus CHG Priming Regimen In Patients With Higher Risk Myelodysplastic Syndrome

Lingyun Wu, Xiao Li, MD, PhD, Feng Xu, Chunkang Chang, Qi He, Zheng Zhang, Luxi Song, Xi Zhang, Jiying Su, Liyu Zhou

Blood (2013) 122 (21): 2789.

https://doi.org/10.1182/blood.V122.21.2789.2789

Published: 2013

Journal Articles

Human Equilibrative Nucleoside Transporter 1 (hENT1) Expression Level Is a Potential Predictive Tool For Response To Decitabine In Patients With Myelodysplastic Syndrome

Lingyun Wu, Xiao Li, MD, PhD, Chunkang Chang, Feng Xu, Qi He, Dong Wu, Jiying Su

Blood (2013) 122 (21): 2790.

https://doi.org/10.1182/blood.V122.21.2790.2790

Published: 2013

Journal Articles

Low RPS14 Expression in MDS without 5q- Aberration Is Associated with Increased Apoptosis of Erythrocytes and Predicts Prolonged Survival and Possible Response to Lenalidomide in Lower-Risk Patients

Lingyun Wu, Xiao Li, MD, PhD, Feng Xu, Yan Zhang, Qi He, Chunkang Chang

Blood (2012) 120 (21): 698.

https://doi.org/10.1182/blood.V120.21.698.698

Published: 2012

Journal Articles

A 15 Mg/M 2 /d Dose of Decitabine Confers Comparable Responses and Better Tolerance Than the Standard Regimen in MDS patients—results of a Multicenter Prospective Cohort Study

Xiao Li, MD, PhD, Qiang Song, MD, Yu Chen, Chunkang Chang, Dong Wu, Lingyun Wu, Jiying Su, Luxi Song, Zheng Zhang, Feng Xu, Ming Hou

Blood (2012) 120 (21): 3832.

https://doi.org/10.1182/blood.V120.21.3832.3832

Published: 2012

Journal Articles

In Vitro Deprivation of CD8 + CD57 + t Cells Promotes the Malignant Growth of Bone Marrow Stem/Progenitor Cells in Patients with Myelodysplastic Syndrome.

Qianqiao Zhang, Xiao Li, MD, PhD, Zheng Zhang, Feng Xu, Qi He, Lingyun Wu, MD, Chunkang Chang

Blood (2009) 114 (22): 1764.

https://doi.org/10.1182/blood.V114.22.1764.1764

Published: 2009

Journal Articles

Removal of Autologous Activated CD4 Positive T Lymphocytes Also Result in Increased Colony-Forming Units (CFUs) in Patients with Myelodysplastic Syndromes.

Zheng Zhang, Xiao Li, MD, PhD, Qingqiao Zhang, Qi He, Feng Xu, Lingyun Wu, MD

Blood (2009) 114 (22): 4862.

https://doi.org/10.1182/blood.V114.22.4862.4862

Published: 2009

Journal Articles

Over-Expression of IGF-IR in Malignant Clonal Cells in Bone Marrow of Myelodysplastic Syndromes.

Qi He, Xiao Li, MD, PhD, Zheng Zhang, Qingqiao Zhang, Feng Xu, Lianping Yang, Ying Tao, Yizhi Liu

Blood (2009) 114 (22): 4832.

https://doi.org/10.1182/blood.V114.22.4832.4832

Published: 2009

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Novel allogeneic BCMA CAR-expressing iNKT cells with PD1 deletion demonstrate superior tumor control in a multiple myeloma preclinical model

Multicenter prospective Phase II study of decitabine priming combined with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed Acute Myeloid Leukemia

Low-dose chemotherapy for induction in pediatric AML: Retrospective outcome analysis across expanded cohorts

Alternative splicing of its 5′-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies

DNMT3A wt NPM1-Mutation Defines a Subgroup of MDS with Special Favorable Outcomes Towards Decitabine Therapy

Incidence, Clinical Characteristics and Outcome of Cardiac Toxicity in Elderly Patients with Diffuse Large B-Cell Lymphoma

Dysregulation of ANKRD11 Influenced Hematopoisis By Histone Acetylation-Mediated Gene Expression in Myelodysplastic Syndrome

Ribosomal Protein L23 Negatively Regulates Cell Apoptosis Via Its Suppression of Miz1 and Activation c-Myc in Higher-Risk Myelodysplastic Syndromes

A Primary Study of the Gene Mutations in Predicting Treatment Response to Decitabine in Patients with MDS

DHX9 Mutations Are Identified As a Novel Recurrent Event in Patients with Myelodysplastic Syndromes and Closely Related to Bone Marrow Failure

EZH2-Mediated Activation of Serine Biosynthetic Pathway Is Critical for Resistance of Clonal Cells to Stress-Related Apoptosis in Low-Grade Myelodysplastic Syndrome

Downregulation of Dicer1 Promotes Cellular Senescence and Decreases the Differentiation and Stem Cell-Supporting Capacities of MSCs in Patients with Myelodysplastic Syndrome

Cytogenetic Response Based On Revised IPSS Cytogenetic Risk Stratification and Minimal Residual Disease Monitoringby FISH In MDS Patients Treated By Low-Dose Decitabine

Efficacy and Toxicity Of Decitabine Versus CHG Priming Regimen In Patients With Higher Risk Myelodysplastic Syndrome

Human Equilibrative Nucleoside Transporter 1 (hENT1) Expression Level Is a Potential Predictive Tool For Response To Decitabine In Patients With Myelodysplastic Syndrome

Low RPS14 Expression in MDS without 5q- Aberration Is Associated with Increased Apoptosis of Erythrocytes and Predicts Prolonged Survival and Possible Response to Lenalidomide in Lower-Risk Patients

A 15 Mg/M 2 /d Dose of Decitabine Confers Comparable Responses and Better Tolerance Than the Standard Regimen in MDS patients—results of a Multicenter Prospective Cohort Study

In Vitro Deprivation of CD8 + CD57 + t Cells Promotes the Malignant Growth of Bone Marrow Stem/Progenitor Cells in Patients with Myelodysplastic Syndrome.

Removal of Autologous Activated CD4 Positive T Lymphocytes Also Result in Increased Colony-Forming Units (CFUs) in Patients with Myelodysplastic Syndromes.

Over-Expression of IGF-IR in Malignant Clonal Cells in Bone Marrow of Myelodysplastic Syndromes.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only